These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1020 related articles for article (PubMed ID: 29620541)

  • 21. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
    Jeong DH; Kang J; Jung YJ; Yoo B; Lee CK; Kim YG; Hong S; Shim TS; Jo KW
    PLoS One; 2018; 13(7):e0198756. PubMed ID: 29975703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.
    del Campo MT; Fouad H; Solís-Bravo MM; Sánchez-Uriz MA; Mahíllo-Fernández I; Esteban J
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1226-34. PubMed ID: 23143360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
    O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
    PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA.
    Nijhawan AE; Iroh PA; Brown LS; Winetsky D; Porsa E
    BMC Infect Dis; 2016 Oct; 16(1):564. PubMed ID: 27733123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting.
    Adams S; Ehrlich R; Baatjies R; Dendukuri N; Wang Z; Dheda K
    Int J Environ Res Public Health; 2019 Aug; 16(16):. PubMed ID: 31416206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.S.
    Wilson FA; Miller TL; Stimpson JP
    Public Health Rep; 2016; 131(2):303-10. PubMed ID: 26957665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of discordant latent tuberculosis infection test results amongst South African health care workers.
    Adams S; Ehrlich R; Baatjies R; Dendukuri N; Wang Z; Dheda K
    BMC Infect Dis; 2019 Feb; 19(1):131. PubMed ID: 30736743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers.
    Harada N; Nakajima Y; Higuchi K; Sekiya Y; Rothel J; Mori T
    Infect Control Hosp Epidemiol; 2006 May; 27(5):442-8. PubMed ID: 16671023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
    Kowada A; Takasaki J; Kobayashi N
    J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of latent tuberculosis infection among migrant farmworkers along the US-Mexico border.
    Oren E; Fiero MH; Barrett E; Anderson B; Nuῆez M; Gonzalez-Salazar F
    BMC Infect Dis; 2016 Nov; 16(1):630. PubMed ID: 27809805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.
    Cho H; Kim YW; Suh CH; Jung JY; Um YJ; Jung JH; Kim HA
    Lupus; 2016 Oct; 25(12):1341-8. PubMed ID: 26985011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculin skin test and interferon-γ release assay in the detection of latent tuberculosis infection among Polish health care workers.
    Targowski T; Chelstowska S; Plusa T
    Pol Arch Med Wewn; 2014; 124(1-2):36-42. PubMed ID: 24343239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of QuantiFERON-TB Gold In-Tube test and Tuberculin Skin Test for diagnosis of latent tuberculosis infection in BCG vaccinated health care workers.
    Babayigit C; Ozer B; Ozer C; Inandi T; Duran N; Gocmen O
    Med Sci Monit; 2014 Mar; 20():521-9. PubMed ID: 24681806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
    de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
    Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers.
    Gandra S; Scott WS; Somaraju V; Wang H; Wilton S; Feigenbaum M
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1279-85. PubMed ID: 20979495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
    Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
    Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
    Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
    Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers.
    Tanabe M; Nakamura A; Arai A; Yamasaki D; Hirano K; Kobayashi T; Taguchi O; Kaneko T; Ito M
    Intern Med; 2017; 56(7):773-779. PubMed ID: 28381742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.